Diagnos Inc.
DGNOF
$0.16
$0.002.17%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -11.72% | -41.40% | -33.73% | -47.76% | -58.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.72% | -41.40% | -33.73% | -47.76% | -58.97% |
| Cost of Revenue | -70.14% | 39.29% | 19.13% | 208.16% | -347.38% |
| Gross Profit | 67.97% | -46.94% | -23.27% | -313.52% | 402.90% |
| SG&A Expenses | -19.11% | -15.41% | 9.64% | 34.37% | 109.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.25% | -0.37% | 12.92% | 69.89% | 73.61% |
| Operating Income | 9.21% | -0.62% | -14.12% | -77.35% | -81.89% |
| Income Before Tax | 8.60% | 3.90% | -6.50% | -53.64% | -55.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.60% | 3.90% | -6.50% | -53.64% | -55.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.60% | 3.90% | -6.50% | -53.64% | -55.33% |
| EBIT | 9.21% | -0.62% | -14.12% | -77.35% | -81.89% |
| EBITDA | 9.13% | -3.49% | -14.48% | -81.61% | -82.93% |
| EPS Basic | 17.02% | 22.83% | 14.29% | -17.91% | -17.50% |
| Normalized Basic EPS | 19.67% | 24.14% | 14.04% | -16.67% | -22.00% |
| EPS Diluted | 17.02% | 22.83% | 14.29% | -17.91% | -17.50% |
| Normalized Diluted EPS | 19.67% | 24.14% | 14.04% | -16.67% | -22.00% |
| Average Basic Shares Outstanding | 10.32% | 25.26% | 24.17% | 30.63% | 32.07% |
| Average Diluted Shares Outstanding | 10.32% | 25.26% | 24.17% | 30.63% | 32.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |